Impact of influenza on hospitalization rates in children with a range of chronic lung diseases.
chronic lung diseases
influenza burden
pediatrics
Journal
Influenza and other respiratory viruses
ISSN: 1750-2659
Titre abrégé: Influenza Other Respir Viruses
Pays: England
ID NLM: 101304007
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
29
08
2018
revised:
19
12
2018
accepted:
31
12
2018
pubmed:
1
2
2019
medline:
18
12
2019
entrez:
1
2
2019
Statut:
ppublish
Résumé
Data on burden of severe influenza in children with a range of chronic lung diseases (CLDs) remain limited. We performed a cohort study to estimate burden of influenza-associated hospitalization in children with CLDs using population-based linked data. The cohort comprised all children in New South Wales, Australia, born between 2001 and 2010 and was divided into five groups, children with: (a) severe asthma; (b) bronchopulmonary dysplasia (BPD); (c) cystic fibrosis (CF); (d) other congenital/chronic lung conditions; and (e) children without CLDs. Incidence rates and rate ratios for influenza-associated hospitalization were calculated for 2001-2011. Average cost/episode of hospitalization was estimated using public hospital cost weights. Our cohort comprised 888 157 children; 11 058 (1.2%) had one of the CLDs. The adjusted incidence/1000 child-years of influenza-associated hospitalization in children with CLDs was 3.9 (95% CI: 2.6-5.2) and 0.7 (95% CI: 0.5-0.9) for children without. The rate ratio was 5.4 in children with CLDs compared to children without. The adjusted incidence/1000 child-years (95% CI) in children with severe asthma was 1.1 (0.6-1.6), with BPD was 6.0 (3.7-8.3), with CF was 7.4 (2.6-12.1), and with other congenital/chronic lung conditions was 6.9 (4.9-8.9). The cost/episode (95% CI) of influenza-associated hospitalization was AUD 19 704 (95% CI: 11 715-27 693) for children with CLDs compared to 4557 (95% CI: 4129-4984) for children without. This large population-based study suggests a significant healthcare burden associated with influenza in children with a range of CLDs.
Sections du résumé
BACKGROUND
Data on burden of severe influenza in children with a range of chronic lung diseases (CLDs) remain limited.
METHOD
We performed a cohort study to estimate burden of influenza-associated hospitalization in children with CLDs using population-based linked data. The cohort comprised all children in New South Wales, Australia, born between 2001 and 2010 and was divided into five groups, children with: (a) severe asthma; (b) bronchopulmonary dysplasia (BPD); (c) cystic fibrosis (CF); (d) other congenital/chronic lung conditions; and (e) children without CLDs. Incidence rates and rate ratios for influenza-associated hospitalization were calculated for 2001-2011. Average cost/episode of hospitalization was estimated using public hospital cost weights.
RESULTS
Our cohort comprised 888 157 children; 11 058 (1.2%) had one of the CLDs. The adjusted incidence/1000 child-years of influenza-associated hospitalization in children with CLDs was 3.9 (95% CI: 2.6-5.2) and 0.7 (95% CI: 0.5-0.9) for children without. The rate ratio was 5.4 in children with CLDs compared to children without. The adjusted incidence/1000 child-years (95% CI) in children with severe asthma was 1.1 (0.6-1.6), with BPD was 6.0 (3.7-8.3), with CF was 7.4 (2.6-12.1), and with other congenital/chronic lung conditions was 6.9 (4.9-8.9). The cost/episode (95% CI) of influenza-associated hospitalization was AUD 19 704 (95% CI: 11 715-27 693) for children with CLDs compared to 4557 (95% CI: 4129-4984) for children without.
DISCUSSION
This large population-based study suggests a significant healthcare burden associated with influenza in children with a range of CLDs.
Identifiants
pubmed: 30701672
doi: 10.1111/irv.12633
pmc: PMC6468072
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
233-239Informations de copyright
© 2019 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.
Références
J Infect Dis. 2006 Nov 1;194 Suppl 2:S133-8
pubmed: 17163386
Pediatr Infect Dis J. 2005 Oct;24(10):931-2
pubmed: 16220098
J Pediatr. 1997 Mar;130(3):400-8
pubmed: 9063415
Pediatrics. 2002 May;109(5):E80-0
pubmed: 11986486
J Am Geriatr Soc. 2002 Apr;50(4):608-16
pubmed: 11982659
Thorax. 1992 Feb;47(2):112-4
pubmed: 1549818
Clin Infect Dis. 2017 Jun 15;64(12):1760-1767
pubmed: 28329304
Pediatrics. 1988 Aug;82(2):199-203
pubmed: 3399292
Allergy. 2007 Feb;62(2):102-12
pubmed: 17298416
Epidemiol Infect. 2016 Jun;144(8):1612-21
pubmed: 26626237
Am J Respir Crit Care Med. 1995 May;151(5):1682-5; discussion 1685-6
pubmed: 7735634
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD001753
pubmed: 19821281
Influenza Other Respir Viruses. 2019 May;13(3):233-239
pubmed: 30701672
N Engl J Med. 2000 Jan 27;342(4):232-9
pubmed: 10648764
Chest. 2010 Apr;137(4):852-60
pubmed: 19965953
Pediatrics. 2008 Jan;121(1):1-8
pubmed: 18166550
N Engl J Med. 1984 Dec 27;311(26):1653-8
pubmed: 6504106
BMJ. 2014 Apr 09;348:g2371
pubmed: 24811409
J Pediatr. 2000 Dec;137(6):856-64
pubmed: 11113844
Expert Rev Vaccines. 2013 Apr;12(4):415-20
pubmed: 23560921
BJOG. 2015 Sep;122(10):1303-11
pubmed: 25754325
Pediatrics. 2013 Dec;132(6):e1539-45
pubmed: 24276847
Pediatr Pulmonol. 1990;8(4):226-32
pubmed: 2371071
N Engl J Med. 2008 Oct 9;359(15):1555-64
pubmed: 18799552
Semin Neonatol. 2003 Feb;8(1):63-71
pubmed: 12667831
Vaccine. 2008 Oct 16;26(44):5612-8
pubmed: 18721838
Arch Pediatr Adolesc Med. 2006 Jul;160(7):713-8
pubmed: 16818837
Med J Aust. 1998 Oct 19;169(S1):S32-5
pubmed: 9830408
J Pediatr. 2014 Jan;164(1):40-45.e4
pubmed: 24055328
Indian J Pediatr. 2007 May;74(5):477-82
pubmed: 17526960